146 related articles for article (PubMed ID: 9207197)
1. The endogenous mu-opioid receptor agonists endomorphins 1 and 2 have novel hypotensive activity in the rabbit.
Champion HC; Zadina JE; Kastin AJ; Hackler L; Ge LJ; Kadowitz PJ
Biochem Biophys Res Commun; 1997 Jun; 235(3):567-70. PubMed ID: 9207197
[TBL] [Abstract][Full Text] [Related]
2. Endomorphin 1 and 2, endogenous mu-opioid agonists, decrease systemic arterial pressure in the rat.
Czapla MA; Champion HC; Zadina JE; Kastin AJ; Hackler L; Ge LJ; Kadowitz PJ
Life Sci; 1998; 62(13):PL175-9. PubMed ID: 9519803
[TBL] [Abstract][Full Text] [Related]
3. Endomorphin 1 and 2, the endogenous mu-opioid agonists, produce biphasic changes in systemic arterial pressure in the cat.
Champion HC; Bivalacqua TJ; Lambert DG; McWilliams SM; Zadina JE; Kastin AJ; Kadowitz PJ
Life Sci; 1998; 63(9):PL131-6. PubMed ID: 9740318
[TBL] [Abstract][Full Text] [Related]
4. Endomorphin-1 and endomorphin-2, endogenous ligands for the mu-opioid receptor, inhibit electrical activity of rat rostral ventrolateral medulla neurons in vitro.
Chu XP; Xu NS; Li P; Wang JQ
Neuroscience; 1999; 93(2):681-6. PubMed ID: 10465452
[TBL] [Abstract][Full Text] [Related]
5. Endomorphin 1 and 2 have vasodepressor activity in the anesthetized mouse.
Champion HC; Zadina JE; Kastin AJ; Kadowitz PJ
Peptides; 1998; 19(5):925-9. PubMed ID: 9663459
[TBL] [Abstract][Full Text] [Related]
6. [Tyr1]-nociceptin, a novel nociceptin analog, decreases systemic arterial pressure by a naloxone-insensitive mechanism in the rat.
Champion HC; Kadowitz PJ
Biochem Biophys Res Commun; 1997 May; 234(2):309-12. PubMed ID: 9177265
[TBL] [Abstract][Full Text] [Related]
7. The endogenous mu-opioid agonists, endomorphin 1 and 2, have vasodilator activity in the hindquarters vascular bed of the rat.
Champion HC; Zadina JE; Kastin AJ; Kadowitz PJ
Life Sci; 1997; 61(26):PL 409-15. PubMed ID: 9416782
[TBL] [Abstract][Full Text] [Related]
8. Vasodepressor responses to [D-Ala2]-endomorphin 2 (TAPP) are mediated by an L-NAME-sensitive mechanism in the rat.
Champion HC; Kadowitz PJ
J Cardiovasc Pharmacol; 1999 Feb; 33(2):280-4. PubMed ID: 10028937
[TBL] [Abstract][Full Text] [Related]
9. Vasorelaxant responses to endomorphins, nociceptin, albuterol, and adrenomedullin in isolated rat aorta.
Hugghins SY; Champion HC; Cheng G; Kadowitz PJ; Jeter JR
Life Sci; 2000 Jun; 67(4):471-6. PubMed ID: 11003057
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular effects of endomorphins in alloxan-induced diabetic rats.
Liu J; Yu Y; Fan YZ; Chang H; Liu HM; Cui Y; Chen Q; Wang R
Peptides; 2005 Apr; 26(4):607-14. PubMed ID: 15752575
[TBL] [Abstract][Full Text] [Related]
11. Structure-constrained endomorphin analogs display differential antinociceptive mechanisms in mice after spinal administration.
Wang Y; Zhou J; Liu X; Zhao L; Wang Z; Zhang X; Wang K; Wang L; Wang R
Peptides; 2017 May; 91():40-48. PubMed ID: 28363796
[TBL] [Abstract][Full Text] [Related]
12. A novel non-opioid binding site for endomorphin-1.
Lengyel I; Toth F; Biyashev D; Szatmari I; Monory K; Tomboly C; Toth G; Benyhe S; Borsodi A
J Physiol Pharmacol; 2016 Aug; 67(4):605-616. PubMed ID: 27779481
[TBL] [Abstract][Full Text] [Related]
13. Reduced suppression of CO2-induced ventilatory stimulation by endomorphins relative to morphine.
Czapla MA; Zadina JE
Brain Res; 2005 Oct; 1059(2):159-66. PubMed ID: 16223471
[TBL] [Abstract][Full Text] [Related]
14. [Tyr1]-nociceptin has naloxone-insensitive vasodilator activity in the hindquarters vascular bed of the rat.
Champion HC; Kadowitz PJ
Life Sci; 1997; 61(26):PL 403-8. PubMed ID: 9416781
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular responses to microinjection of nociceptin and endomorphin-1 into the nucleus tractus solitarii in conscious rats.
Mao L; Wang JQ
Neuroscience; 2005; 132(4):1009-15. PubMed ID: 15857705
[TBL] [Abstract][Full Text] [Related]
16. Nociceptin, an endogenous ligand for the ORL1 receptor, has novel hypotensive activity in the rat.
Champion HC; Kadowitz PJ
Life Sci; 1997; 60(16):PL 241-5. PubMed ID: 9096263
[TBL] [Abstract][Full Text] [Related]
17. Spinal analgesic actions of the new endogenous opioid peptides endomorphin-1 and -2.
Stone LS; Fairbanks CA; Laughlin TM; Nguyen HO; Bushy TM; Wessendorf MW; Wilcox GL
Neuroreport; 1997 Sep; 8(14):3131-5. PubMed ID: 9331928
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of endomorphin-1 and endomorphin-2 in mouse brain.
Goldberg IE; Rossi GC; Letchworth SR; Mathis JP; Ryan-Moro J; Leventhal L; Su W; Emmel D; Bolan EA; Pasternak GW
J Pharmacol Exp Ther; 1998 Aug; 286(2):1007-13. PubMed ID: 9694962
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular responses to intrathecal administration of endomorphins in anesthetized rats.
Wang CL; Yu Y; Lai LH; Cui Y; Wang X; Wang R
Peptides; 2007 Apr; 28(4):871-7. PubMed ID: 17307277
[TBL] [Abstract][Full Text] [Related]
20. Endomorphin 1 and 2, endogenous ligands for the mu-opioid receptor, decrease cardiac output, and total peripheral resistance in the rat.
Champion HC; Zadina JE; Kastin AJ; Hackler L; Ge LJ; Kadowitz PJ
Peptides; 1997; 18(9):1393-7. PubMed ID: 9392842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
